Biolase Technology, Inc. (BLTI)

Biolase Technology, Inc. is related to 2 other symbols. To date we've encountered 10 releases involving Biolase Technology, Inc..

Last Price: 1.05 (+0.01) - 1/7/2009, 4:00pm

• Open: 1.04
• High: 1.05
• Low: 0.99

Biolase Technology, Inc. Options

• Biolase Technology, Inc. "Business Partners"
• Biolase Technology, Inc. Press Releases
• Biolase Technology, Inc. News
• Biolase Technology, Inc. Contact
• Biolase Technology, Inc. Related (via TRYNT)

Biolase Technology, Inc. "Business Partners"

A "business partner" is defined as a third party company that has co-released at least one press release with Biolase Technology, Inc..

• FCSE
• VKPW

^

Biolase Technology, Inc. Press Releases

• BIOLASE Technology, Inc.: BIOLASE Receives European Patent for Its Laser Pulse Technology (Trackbacks) (Backlinks), Wed, 25 Oct 2006 4:00:00 PDT

  IRVINE, CA (MARKET WIRE) BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today it has been granted a new European patent related to proprietary laser and pulse technology with claims covering key laser pulse structures, as well as soft and hard tissue

• BIOLASE Technology, Inc.: BIOLASE Receives Notice That It Has Adequately Addressed the Concerns Raised in the FDA Warning Letter (Trackbacks) (Backlinks), Fri, 29 Sep 2006 4:00:00 PDT

  IRVINE, CA (MARKET WIRE) BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that it received a letter from the FDA stating that the FDA had completed its review of the Company's response to the Warning Letter dated September 5, 2006. The FDA

• BIOLASE Technology, Inc.: BIOLASE Receives New Patent for Its Laser Pulse Technology (Trackbacks) (Backlinks), Tue, 26 Sep 2006 4:00:00 PDT

  IRVINE, CA (MARKET WIRE) BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today it has been granted a new U.S. patent related to its proprietary laser and pulse technology with claims covering diode pumping excitation, key pulse structures as well as

• BIOLASE Technology, Inc.: BIOLASE to Present at UBS Global Life Sciences Conference (Trackbacks) (Backlinks), Thu, 21 Sep 2006 9:33:00 PDT

  IRVINE, CA (MARKET WIRE) BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that President and CEO Jeffrey W. Jones and CFO Richard L. Harrison are scheduled to make an investor presentation at the UBS Global Life Sciences Conference at 2:30

• BIOLASE Technology, Inc.: BIOLASE Comments on Receipt of FDA Warning Letter (Trackbacks) (Backlinks), Mon, 11 Sep 2006 11:17:00 PDT

  IRVINE, CA (MARKET WIRE) BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that on September 7, 2006, it received a Warning Letter from the Los Angeles District Office of the United States Food and Drug Administration ("FDA") following an

• BIOLASE Technology, Inc.: BIOLASE Announces FDA Clearance of Its OCULASE MD(TM) Laser System for Ophthalmology (Trackbacks) (Backlinks), Thu, 13 Jul 2006 4:00:00 PDT

  IRVINE, CA (MARKET WIRE) BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) allowing it to market its OCULASE MD(TM) Laser System for general ophthalmic soft

• BIOLASE Technology, Inc.: BIOLASE Appoints Keith G. Bateman as Executive Vice President, Global Sales and Marketing (Trackbacks) (Backlinks), Wed, 17 May 2006 10:18:00 PDT

  IRVINE, CA (MARKET WIRE) BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today the appointment of Keith G. Bateman as Executive Vice President, Global Sales and Marketing. Mr. Bateman was previously serving as the Company's Executive Vice President, Marketing.

• BIOLASE Technology, Inc.: BIOLASE to Present at the 2006 Bank of America Health Care Conference (Trackbacks) (Backlinks), Tue, 16 May 2006 12:17:00 PDT

  IRVINE, CA (MARKET WIRE) BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that Jeffrey W. Jones, President and CEO, and Richard L. Harrison, Executive Vice President and CFO, will present at the 2006 Bank of America Health Care Conference in

• BIOLASE Technology, Inc.: BIOLASE Announces First Quarter 2006 Results; Management and Board Changes (Trackbacks) (Backlinks), Tue, 9 May 2006 13:07:00 PDT

  IRVINE, CA (MARKET WIRE) BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, today reported operating results for the first quarter ended March 31, 2006. The Company also announced that Robert E. Grant, the Company's President, CEO and Acting Chairman of the

• BIOLASE Technology, Inc.: BIOLASE Moves Into New Corporate Headquarters in Irvine, CA (Trackbacks) (Backlinks), Mon, 1 May 2006 12:41:00 PDT

  IRVINE, CA (MARKET WIRE) BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that it has moved into its new corporate headquarters in Irvine, California. The new building will provide the Company with more efficient office and manufacturing space as well as room for continued growth.

^

Biolase Technology, Inc. News

• BIOLASE TECHNOLOGY INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online), Tue, 30 Dec 2008 22:28:12 Etc/GMT
• BIOLASE Announces First Nationally Televised Laser Root Canal Procedure to Be Broadcast January 8 (Marketwire), Tue, 30 Dec 2008 11:00:00 Etc/GMT
• Scana, Owens-Illinois, FLIR to join S&P 500 Index (AP), Wed, 24 Dec 2008 01:29:11 Etc/GMT
• Standard & Poor's Announces Changes to U.S. Indices (PR Newswire), Tue, 23 Dec 2008 23:11:00 Etc/GMT
• BIOLASE to Present at the Needham Growth Stock Conference in New York City (Marketwire), Tue, 23 Dec 2008 11:00:00 Etc/GMT
• BIOLASE TECHNOLOGY INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Right (EDGAR Online), Mon, 22 Dec 2008 11:03:22 Etc/GMT
• BIOLASE TECHNOLOGY INC Files SEC form 8-K, Other Events (EDGAR Online), Tue, 2 Dec 2008 16:32:59 Etc/GMT
• Biolase trims costs with 20 percent job cut (AP), Tue, 2 Dec 2008 12:29:49 Etc/GMT
• BIOLASE Cuts Quarterly Fixed Costs by $2 Million or 20 Percent (Marketwire), Tue, 2 Dec 2008 11:00:00 Etc/GMT
• BIOLASE TECHNOLOGY INC Financials (EDGAR Online Financials), Fri, 14 Nov 2008 14:04:22 Etc/GMT
• BIOLASE TECHNOLOGY INC Files SEC form 10-Q, Quarterly Report (EDGAR Online), Fri, 7 Nov 2008 21:42:47 Etc/GMT
• BIOLASE TECHNOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online), Wed, 5 Nov 2008 21:19:40 Etc/GMT
• BIOLASE Reports Third Quarter, Nine-Month Results (Marketwire), Wed, 5 Nov 2008 21:05:00 Etc/GMT
• Q3 2008 BioLase Technology Earnings Release - After Market Close (CCBN), Wed, 5 Nov 2008 12:07:14 Etc/GMT
• BIOLASE Conference Call: 2008 Third Quarter and Nine-Month Results (GlobeNewswire), Thu, 30 Oct 2008 10:00:00 Etc/GMT
• BIOLASE Formalizes Luminary Group and Establishes Advisory Board for Customer Service and Training (Marketwire), Tue, 14 Oct 2008 11:30:00 Etc/GMT
• BIOLASE TECHNOLOGY INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online), Tue, 14 Oct 2008 10:21:31 Etc/GMT
• BIOLASE TECHNOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online), Thu, 9 Oct 2008 10:07:01 Etc/GMT
• BIOLASE Names William E. Brown Vice President, International (Marketwire), Thu, 9 Oct 2008 10:00:00 Etc/GMT
• BIOLASE Granted First Japanese Patent (Marketwire), Mon, 22 Sep 2008 10:00:00 Etc/GMT

^

Biolase Technology, Inc. Contact

• For further information, please contact:
  Jeffrey W. Jones
  President & CEO
  
  Richard L. Harrison
  Executive Vice President and CFO
  
  Scott Jorgensen
  Vice President - Business Development
  
  BIOLASE Technology, Inc.
  +1-949-361-1200
  
  

TRYNT Related

• TRYNT did not suggest any related symbols

^

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.